Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SnoreStop, a brand under Green Pharmaceuticals Inc., is a specialized healthcare company focused on providing natural, homeopathic solutions for snoring. Founded in 1995, the company offers a range of over-the-counter products including chewable tablets, nasal sprays, and throat sprays. Their formulations are designed to address the physiological causes of snoring, such as airway inflammation and congestion, using ingredients listed in the Homeopathic Pharmacopoeia of the United States. SnoreStop is notable for having conducted a double-blind, placebo-controlled clinical study to validate the efficacy of its products, a rarity in the homeopathic industry. The company's products are widely distributed through major retail pharmacies and online platforms. SnoreStop continues to be a prominent name in the non-device anti-snoring market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SnoreStop.